Penserra Capital Management LLC Selecta Biosciences Inc Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$2.89 - $4.43 $7,600 - $11,650
-2,630 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$3.36 - $4.62 $184 - $254
55 Added 2.14%
2,630 $10,000
Q2 2021

Aug 12, 2021
BUY
$2.82 - $5.01 $338 - $601
120 Added 4.89%
2,575 $10,000
Q1 2021

May 13, 2021
SELL
$2.92 - $5.07 $73 - $126
-25 Reduced 1.01%
2,455 $11,000
Q4 2020

Feb 12, 2021
BUY
$1.64 - $3.42 $4,067 - $8,481
2,480 New
2,480 $7,000

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email